These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 16140936)
1. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Polette M; Gilles C; Nawrocki-Raby B; Lohi J; Hunziker W; Foidart JM; Birembaut P Cancer Res; 2005 Sep; 65(17):7691-8. PubMed ID: 16140936 [TBL] [Abstract][Full Text] [Related]
3. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284 [TBL] [Abstract][Full Text] [Related]
4. The E-cadherin-repressed hNanos1 gene induces tumor cell invasion by upregulating MT1-MMP expression. Bonnomet A; Polette M; Strumane K; Gilles C; Dalstein V; Kileztky C; Berx G; van Roy F; Birembaut P; Nawrocki-Raby B Oncogene; 2008 Jun; 27(26):3692-9. PubMed ID: 18223680 [TBL] [Abstract][Full Text] [Related]
5. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090 [TBL] [Abstract][Full Text] [Related]
6. E1AF expression is closely correlated with malignant phenotype of tongue squamous cell carcinoma through activation of MT1-MMP gene promoters. Izumiyama Y; Ohiro Y; Higashino F; Yoshida K; Taguchi K; Todo S; Kohgo T; Totsuka Y; Shindoh M Oncol Rep; 2005 Apr; 13(4):715-20. PubMed ID: 15756447 [TBL] [Abstract][Full Text] [Related]
7. Transactivation of vimentin by beta-catenin in human breast cancer cells. Gilles C; Polette M; Mestdagt M; Nawrocki-Raby B; Ruggeri P; Birembaut P; Foidart JM Cancer Res; 2003 May; 63(10):2658-64. PubMed ID: 12750294 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249 [TBL] [Abstract][Full Text] [Related]
10. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. Lara-Pezzi E; Gómez-Gaviro MV; Gálvez BG; Mira E; Iñiguez MA; Fresno M; Martínez-A C; Arroyo AG; López-Cabrera M J Clin Invest; 2002 Dec; 110(12):1831-8. PubMed ID: 12488433 [TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of MT1-MMP antisense nucleotide on invasion of human highly metastatic ovarian cancer cell line SW626]. Wu MF; Liao GN; Jia P; Xi L; Lu YP; Ma D Ai Zheng; 2004 Nov; 23(11):1263-6. PubMed ID: 15522170 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells. Wu M; Xu G; Xi L; Wei J; Song A; Han Z; Zhou J; Wang S; Zhu T; Zhang A; Lu Y; Ma D Oncol Rep; 2006 Feb; 15(2):501-5. PubMed ID: 16391876 [TBL] [Abstract][Full Text] [Related]
13. Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors. Ueda J; Kajita M; Suenaga N; Fujii K; Seiki M Oncogene; 2003 Nov; 22(54):8716-22. PubMed ID: 14647466 [TBL] [Abstract][Full Text] [Related]
14. [Significance of membrane type-1 matrix metalloproteinase expression in breast cancer]. Yao GY; Yang MT; Rong TH; He P Ai Zheng; 2004 Nov; 23(11 Suppl):1482-6. PubMed ID: 15566663 [TBL] [Abstract][Full Text] [Related]
15. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252 [TBL] [Abstract][Full Text] [Related]
16. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585 [TBL] [Abstract][Full Text] [Related]
17. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis. Ueda M; Yamashita Y; Takehara M; Terai Y; Kumagai K; Ueki K; Kanda K; Hung YC; Ueki M Gynecol Endocrinol; 2002 Oct; 16(5):391-402. PubMed ID: 12587534 [TBL] [Abstract][Full Text] [Related]
18. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas. Kitagawa Y; Kunimi K; Ito H; Sato H; Uchibayashi T; Okada Y; Seiki M; Namiki M J Urol; 1998 Oct; 160(4):1540-5. PubMed ID: 9751409 [TBL] [Abstract][Full Text] [Related]
19. beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Lowy AM; Clements WM; Bishop J; Kong L; Bonney T; Sisco K; Aronow B; Fenoglio-Preiser C; Groden J Cancer Res; 2006 May; 66(9):4734-41. PubMed ID: 16651426 [TBL] [Abstract][Full Text] [Related]
20. Retroviral gene transfer of an antisense construct against membrane type 1 matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial fibroblasts. Rutkauskaite E; Volkmer D; Shigeyama Y; Schedel J; Pap G; Müller-Ladner U; Meinecke I; Alexander D; Gay RE; Drynda S; Neumann W; Michel BA; Aicher WK; Gay S; Pap T Arthritis Rheum; 2005 Jul; 52(7):2010-4. PubMed ID: 15986375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]